Related Experiment Video

Updated: Jun 27, 2026

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Published on: February 24, 2023

Pharmacotherapy for adults with tumors of the central nervous system

Nina F Schor1

  • 1Departments of Pediatrics, Neurology, and Neurobiology & Anatomy, University of Rochester Medical Center, Rochester, NY, USA. nina_schor@urmc.rochester.edu

Pharmacology & Therapeutics
|December 19, 2008
PubMed

Insights

Adult central nervous system tumors are common and chemoresistant, necessitating new treatments. This review explores current pharmacotherapy challenges and novel strategies for malignant brain and spinal cord tumors.

Area of Science:

  • Neuro-oncology
  • Cancer Pharmacology
  • Central Nervous System Neoplasms

Background:

  • Malignant tumors of the adult central nervous system (CNS) represent a significant oncological challenge.
  • These neoplasms are notoriously chemoresistant, contributing to poor patient outcomes.
  • CNS tumors account for approximately 1.3% of all cancers and 2.2% of cancer deaths.

Purpose of the Study:

  • To review current pharmacotherapy approaches for adult malignant CNS tumors.
  • To identify key challenges hindering successful drug treatment in these patients.
  • To discuss emerging and novel strategies for overcoming treatment resistance.

Main Methods:

  • Comprehensive literature review of existing research on CNS tumor pharmacotherapy.
  • Analysis of current treatment protocols and their limitations.
  • Exploration of innovative pharmacological agents and therapeutic modalities.

Main Results:

  • Current pharmacotherapy faces significant hurdles due to the blood-brain barrier and tumor heterogeneity.
  • Limited efficacy of conventional chemotherapeutic agents in achieving durable responses.
  • Identification of promising novel targets and drug delivery systems.

Conclusions:

  • There is an urgent need for advanced pharmacological strategies to treat adult malignant CNS tumors.
  • Overcoming chemoresistance and improving drug delivery are critical for therapeutic success.
  • Future research should focus on targeted therapies and innovative treatment combinations.

More Related Videos

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice05:39

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...